Effects of thymectomy on late-onset non-thymomatous myasthenia gravis: systematic review and meta-analysis

被引:18
作者
Zhang, Jinwei [1 ]
Chen, Yuan [1 ]
Zhang, Hui [1 ]
Yang, Zhaoyu [1 ]
Zhang, Peng [1 ]
机构
[1] Tianjin Med Univ, Gen Hosp, Dept Cardiothorac Surg, 154 Anshan Rd, Tianjin, Peoples R China
关键词
Myasthenia gravis; Early onset; Late onset; Thymectomy; Remission; Systematic review; THORACOSCOPIC EXTENDED THYMECTOMY; QUALITY;
D O I
10.1186/s13023-021-01860-y
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background The effects of thymectomy on late-onset non-thymomatous myasthenia gravis (NTMG) remain controversial. The objective of this study was to conduct a systematic review in order to answer two questions pertinent to late-onset NTMG: (1) do patients with late-onset NTMG experience the same effects from thymectomy as their early-onset counterparts? (2) Compared with conservative treatment, does thymectomy have any benefits for late-onset NTMG patients? Methods We searched the PubMed, EMBASE, and Cochrane Library databases for studies published from January 1, 1950 to March 10, 2021. Outcomes were measured via clinical stable remission/pharmacological remission (CSR/PR) and improvement rates. We used Stata software to analyze the data. Results We ultimately included a total of 12 observational articles representing the best evidence answering the questions of our study objective. Of these, nine studies, which included 896 patients overall (766 early-onset and 230 late-onset), compared postoperative outcomes between early- and late-onset NTMG. The remaining three articles, which included 216 patients (75 in the thymectomy group and 141 in the conservative-treatment group), compared thymectomy with conservative treatment for late-onset NTMG. The early- versus late-onset NTMG studies demonstrated that patients in the former category were 1.95x likelier than their late-onset counterparts to achieve clinical remission (odds ratio [OR] 1.95; 95% confidence interval [CI] 1.39-2.73; I-2 = 0%). No difference was seen in improvement or remission + improvement rates between these two groups. When comparing thymectomy with conservative treatments in late-onset NTMG patients, neither did we observe any difference in CSR/PR. Conclusion We found that late-onset NTMG patients had a lower chance of achieving CSR after thymectomy than early-onset patients. Thymectomy in late-onset NTMG also yielded no benefit to CSR or PR compared with conservative treatments. In late-onset NTMG patients, thymectomy should therefore be performed with caution, and the appropriate cutoff between early- and late-onset MG should be further explored in order to tailor and execute the proper therapeutic strategies.
引用
收藏
页数:14
相关论文
共 35 条
  • [1] Late-onset myasthenia gravis - A changing scene
    Aarli, JA
    [J]. ARCHIVES OF NEUROLOGY, 1999, 56 (01) : 25 - 27
  • [2] Treatment of Myasthenia Gravis in the Aged
    Alkhawajah, Nuha M.
    Oger, Joel
    [J]. DRUGS & AGING, 2015, 32 (09) : 689 - 697
  • [3] Thymectomy is more effective than conservative treatment for myasthenia gravis regarding outcome and clinical improvement
    Bachmann, Kai
    Burkhardt, Doreen
    Schreiter, Inken
    Kaifi, Jussuf
    Schurr, Paulus
    Busch, Christoph
    Thayssen, Gunther
    Izbicki, Jakob R.
    Strate, Tim
    [J]. SURGERY, 2009, 145 (04) : 392 - 398
  • [4] Thymectomy for non-thymomatous myasthenia gravis: a propensity score matched study
    Barnett, Carolina
    Katzberg, Hans D.
    Keshavjee, Shaf
    Bril, Vera
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2014, 9 : 214
  • [5] Thymectomy in nonthymomatous myasthenia gravis - systematic review and meta-analysis
    Cataneo, Antonio J. M.
    Felisberto, Gilmar, Jr.
    Cataneo, Daniele C.
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
  • [6] Incidence, mortality, and economic burden of myasthenia gravis in China: A nationwide population-based study
    Chen, Jingshan
    Tian, De-Cai
    Zhang, Chao
    Li, Zixiao
    Zhai, Yi
    Xiu, Yuwen
    Gu, Hongqiu
    Li, Hao
    Wang, Yongjun
    Shi, Fu-Dong
    [J]. LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2020, 5
  • [7] Clinical and therapeutic features of myasthenia gravis in adults based on age at onset
    Cortes-Vicente, Elena
    Alvarez-Velasco, Rodrigo
    Segovia, Sonia
    Paradas, Carmen
    Casasnovas, Carlos
    Guerrero-Sola, Antonio
    Pardo, Julio
    Ramos-Fransi, Alba
    Sevilla, Teresa
    Lopez de Munain, Adolfo
    Teresa Gomez, Maria
    Jerico, Ivonne
    Gutierrez-Gutierrez, Gerardo
    Lara Pelayo-Negro, Ana
    Asuncion Martin, Maria
    Dolores Mendoza, Maria
    Moris, German
    Rojas-Garcia, Ricard
    Diaz-Manera, Jordi
    Querol, Luis
    Gallardo, Eduard
    Velez, Beatriz
    Antonia Alberti, Maria
    Galan, Lucia
    Garcia-Sobrino, Tania
    Martinez-Pineiro, Alicia
    Lozano-Veintimilla, Ana
    Fernandez-Torron, Roberto
    Cano-Abascal, Angel
    Illa, Isabel
    [J]. NEUROLOGY, 2020, 94 (11) : E1171 - E1180
  • [8] Deenen Johanna C W, 2015, J Neuromuscul Dis, V2, P73
  • [9] THYMECTOMY FOR THE MYASTHENIA-GRAVIS PATIENT - FACTORS INFLUENCING OUTCOME
    FRIST, WH
    THIRUMALAI, S
    DOEHRING, CB
    MERRILL, WH
    STEWART, JR
    FENICHEL, GM
    BENDER, HW
    [J]. ANNALS OF THORACIC SURGERY, 1994, 57 (02) : 334 - 338
  • [10] Myasthenia gravis
    Gilhus, Nils Erik
    Tzartos, Socrates
    Evoli, Amelia
    Palaces, Jacqueline
    Burns, Ted M.
    Verschuuren, Jan J. G. M.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2019, 5